AUM Biosciences

Singapore, Singapore · Founded 2018 · Privately Held (backing)

Developer of an oncology-focused biotechnology platform designed to help in harnessing the power of digital and precision medicine. AUM Biosciences is based in Singapore, Singapore and was founded in 2018. Its last reported valuation was $98.7 million in Oct 2021. It has raised $29.7 million.

Last reported valuation
$98.7M
Oct 2026
Priced at
—
Total raised
$29.7M
Last round
—

Who backs AUM Biosciences?

9 investors
InvestorType
SPRIM Global InvestmentsOther
ASA Capital Partners—
Accelerate Technologies—
Agency for Science—
Anexa Capital (US)—
Everlife Asia—
Premkumar Pillay—
Pureland Group—
Technology and Research—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AUM Biosciences investors

9 investors are on record for AUM Biosciences, including SPRIM Global Investments, ASA Capital Partners, Accelerate Technologies and Agency for Science.

Free account
More of AUM Biosciences with a free account
  • ·Watch AUM Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like AUM Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View